My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

Black Diamond Therapeutics, Inc. - Common Stock (NQ:BDTX)

2.655 -0.055 (-2.03%)

Streaming Delayed Price Updated: 12:37 PM EST, Dec 10, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Black Diamond Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 Next >

4 Biotechnology Stocks Lead Momentum Gains Amid Strong Technicals ↗

October 10, 2025

4 biotech stocks—ALDX, ALEC, BDTX, CHRS—show strong week-on-week momentum ranking gains and improving technical indicators.

Via Benzinga

Black Diamond (BDTX) Q2 Loss Narrows 47% ↗

August 07, 2025

Via The Motley Fool

These stocks have an unusual volume in today's session ↗

March 21, 2025

These stocks have an unusual volume in today's session

Via Chartmill

Unusual volume stocks in Thursday's session ↗

March 20, 2025

Let's have a look at what is happening on the US markets on Thursday. Below you can find the stocks with an unusual volume in today's session.

Via Chartmill

Looking Into Black Diamond Therapeutic's Recent Short Interest ↗

August 22, 2024

Via Benzinga

Black Diamond Therapeutic: Q4 Earnings Insights ↗

March 12, 2024

Via Benzinga

What 6 Analyst Ratings Have To Say About Black Diamond Therapeutic ↗

September 12, 2023

Via Benzinga

Where Black Diamond Therapeutic Stands With Analysts ↗

July 14, 2023

Via Benzinga

These stocks are the most active in today's session ↗

March 19, 2025

These stocks are making the most noise in today's session. Stay tuned for the latest updates!

Via Chartmill

What's going on in today's session ↗

March 19, 2025

Let's have a look at what is happening on the US markets in the middle of the day on Wednesday. Below you can find the top gainers and losers in today's session.

Via Chartmill

Black Diamond Therapeutics Shares Jump On New Partnership With France-Based Servier: Retail Sentiment Hits Year-High ↗

March 19, 2025

As part of the deal, Servier will develop and commercialize the clinical-stage oncology company’s BDTX-4933, a molecule designed to address solid tumors, including non-small cell lung cancer.

Via Stocktwits

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

March 19, 2025

Via Benzinga

Wednesday's session: gap up and gap down stocks ↗

March 19, 2025

Let's have a look at what is happening on the US markets on Wednesday. Below you can find the gap up and gap down stocks in today's session.

Via Chartmill

Black Diamond Therapeutics Inks Licensing Pact With French Pharma Firm Servier For Its Early-Stage Cancer Drug Worth Over $700 Million ↗

March 19, 2025

Servier announces a strategic worldwide licensing agreement for Black Diamond Therapeutics' BDTX-4933 for solid tumors for an upfront payment of $70 million and up to $710 million in milestone...

Via Benzinga

Discover the top movers in Wednesday's pre-market session. ↗

March 19, 2025

Wondering what's happening in Wednesday's pre-market session? Find an overview in this article.

Via Chartmill

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

March 19, 2025

Via Benzinga

Why Sage Therapeutics Shares Are Trading Higher By Over 34%; Here Are 20 Stocks Moving Premarket ↗

January 13, 2025

Via Benzinga

Black Diamond Therapeutics' Lead Drug Candidate Shows Initial Anti-tumor Activity In Certain Type Of Lung Cancer Resistant To AstraZeneca's Drug ↗

September 23, 2024

Black Diamond Therapeutics reports promising initial Phase 2 data for BDTX-1535 in relapsed EGFR-mutant NSCLC patients. With a 36% objective response rate and encouraging durability, BDTX-1535 shows...

Via Benzinga

BDTX Stock Earnings: Black Diamond Therapeutic Beats EPS for Q2 2024 ↗

August 06, 2024

BDTX stock results show that Black Diamond Therapeutic beat analyst estimates for earnings per share the second quarter of 2024.

Via InvestorPlace

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

June 11, 2024

Via Benzinga

BDTX Stock Earnings: Black Diamond Therapeutic Beats EPS for Q1 2024 ↗

May 09, 2024

BDTX stock results show that Black Diamond Therapeutic beat analyst estimates for earnings per share the first quarter of 2024.

Via InvestorPlace

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

April 23, 2024

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

December 13, 2023

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

December 08, 2023

Via Benzinga

Black Diamond Therapeutics And 2 Other Stocks Under $3 Insiders Are Buying ↗

October 20, 2023

The Dow Jones closed lower by around 250 points on Thursday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders...

Via Benzinga

Topics Stocks

10 Health Care Stocks Whale Activity In Today's Session ↗

September 18, 2023

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For July 14, 2023 ↗

July 14, 2023

Via Benzinga

$4.7M Bet On Black Diamond Therapeutics? Check Out These 3 Stocks Insiders Are Buying ↗

July 10, 2023

Although US stocks closed lower on Friday, there were a few notable insider trades.

Via Benzinga

Why Icahn Enterprises Shares Are Trading Higher By 18%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

July 10, 2023

Gainers Mobilicom Limited (NASDAQ: MOB) shares jumped 81.3% to $2.7187 after the company announced it received a commercial scale purchase order from Teledyne-FLIR for the production of drones for the...

Via Benzinga

Nanobiotix, NanoString Technologies And Other Big Stocks Moving Higher In Monday's Pre-Market Session ↗

July 10, 2023

U.S. stock futures traded lower this morning. Here are some big stocks recording gains in today’s pre-market trading session.

Via Benzinga

< Previous 1 2 3 4 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.